{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:55:57Z","timestamp":1780581357591,"version":"3.54.1"},"reference-count":61,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100004515","name":"The National University of Malaysia (UKM)","doi-asserted-by":"publisher","award":["DLP-2014-009"],"award-info":[{"award-number":["DLP-2014-009"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"<jats:sec>\n<jats:title>\n<\/jats:title>\n<jats:p>Attention deficit hyperactive disorder (ADHD), a hyperactivity disorder prevalent among\nchildren may continue as an adulthood attention deficit. To date, treating an individual with an adult\nADHD may be an arduous task as it involves numerous challenges, which include a need for high index\nof suspicion to diagnose this medical condition. Many psychiatric disorders masquerade as\nADHD and delay the necessary assessment and proper treatment for this debilitating medical disorder.\nAdult ADHD is often misdiagnosed (or under diagnosed) due to the fact that this medical condition is\nbeing masked by the patients\u2019 high level of intellectual achievement. As the ADHD in adult persists, it\nmay end-up with impairment in the personal-social-occupational function in which the management\nbecomes a great challenge. The treatment of ADHD can be optimized by using various drugs targets\nagents like norepinephrine-dopamine reuptake inhibitor (NDRI), with or without psycho stimulants\nlike methylphenidate, which is marketed as Ritalin. Bupropion, an NDRI has a novel effect on ADHD\nas the molecule exerts its effects by modulating the reward-pleasure mesolimbic dopaminergic system\nand at the same time regulates the elevating mood dimension of the noradrenergic neurotransmission.\nThe role of Bupropion in the neural and psychopharmacological perspective treatment of ADHD was\ndeliberated. The present review highlights the novel effects of Bupropion in ADHD treatment, together\nwith the help of other successful bio-psycho-social measures. This may be of immense benefit\nto the psychiatrists for treating their patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450118666170511145628","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T15:09:20Z","timestamp":1494601760000},"page":"210-219","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder"],"prefix":"10.2174","volume":"20","author":[{"given":"Kanit Tha","family":"Deang","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre Jalan Yaacob Latif Bandar Tun Razak 56000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatta","family":"Sidi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre Jalan Yaacob Latif Bandar Tun Razak 56000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazli","family":"Zakaria","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre Jalan Yaacob Latif Bandar Tun Razak 56000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Lope","family":"Adam","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre Jalan Yaacob Latif Bandar Tun Razak 56000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijit","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre Jalan Yaacob Latif Bandar Tun Razak 56000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurul Hazwani","family":"Hatta","sequence":"additional","affiliation":[{"name":"National University of Galway, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hizri","family":"Hatta","sequence":"additional","affiliation":[{"name":"Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Wei","family":"Wee","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universiti Sultan Zainal Abidin, 20400 Kampus Kota, Kuala Terengganu, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":""},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00004703-200610000-00008","volume":"27","author":"Lopez F.A.","year":"2006","unstructured":"Lopez FA.  ADHD: New pharmacological treatments on the horizon.","journal-title":"J Dev Behav Pediatr"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/1087054707310878","volume":"11","author":"Davidson M.A.","year":"2007","unstructured":"Davidson MA.  ADHD in adults: a review of the literature.","journal-title":"J Atten Disord"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00004583-199503000-00020","volume":"34","author":"Achenbach T.M.","year":"1995","unstructured":"Achenbach TM, Howell CT, McConaughy SH, Stanger C.  Six-year predictors of problems in a national sample of children and youth: I. Cross-informant syndromes.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/BF01447474","volume":"23","author":"Hart E.L.","year":"1995","unstructured":"Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ.  Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study.","journal-title":"J Abnorm Child Psychol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4088\/JCP.08m04785pur","volume":"70","author":"Wilens T.E.","year":"2009","unstructured":"Wilens TE, Biederman J, Faraone SV, Martelon M, Westerberg D, Spencer TJ.  Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD.","journal-title":"J Clin Psychiatry"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.disamonth.2007.01.001","volume":"53","author":"Greydanus D.E.","year":"2007","unstructured":"Greydanus DE, Pratt HD, Patel DR.  Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.","journal-title":"Dis Mon"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0010-440X(96)90022-X","volume":"37","author":"Murphy K.","year":"1996","unstructured":"Murphy K, Barkley RA.  Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments.","journal-title":"Compr Psychiatry"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12402-016-0208-3","volume":"9","author":"Fayyad J.","year":"2016","unstructured":"Fayyad J, Sampson NA, Hwang I.  The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys.","journal-title":"Atten Defic Hyperact Disord"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev.med.53.082901.103945","volume":"53","author":"Wilens T.E.","year":"2002","unstructured":"Wilens TE, Biederman J, Spencer TJ.  Attention deficit \/hyperactivity disorder across the lifespan.","journal-title":"Annu Rev Med"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0033291705006410","volume":"36","author":"Biederman J.","year":"2006","unstructured":"Biederman J, Monuteaux MC, Mick E.  Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study.","journal-title":"Psychol Med"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-3223(02)01664-5","volume":"54","author":"Wilens T.E.","year":"2003","unstructured":"Wilens TE, Prince JB, Spencer T.  An open trial of bupropion for the treatment of adults with attention-deficit\/hyperactivity disorder and bipolar disorder.","journal-title":"Biol Psychiatry"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/7854_2011_125","volume":"9","author":"Heal D.J.","year":"2012","unstructured":"Heal DJ, Smith SL, Findling RL.  ADHD: current and future therapeutics.","journal-title":"Curr Top Behav Neurosci"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1440-1819.2011.02264.x","volume":"65","author":"Maneeton N.","year":"2011","unstructured":"Maneeton N, Maneeton B, Srisurapanont M, Martin SD.  Bupropion for adults with attention-deficit hyperactivity disorder: Meta-analysis of randomized, placebo-controlled trials.","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=15","first-page":"245","volume":"1","author":"Reimherr F.W.","year":"2005","unstructured":"Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED.  Bupropion SR in adults with ADHD: A short-term, placebo-controlled trial.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=16","unstructured":""},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14737175.6.9.1249","volume":"6","author":"Foley K.F.","year":"2006","unstructured":"Foley KF, DeSanty KP, Kast RE.  Bupropion: Pharmacology and therapeutic applications.","journal-title":"Expert Rev Neurother"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","volume":"54","author":"Learned-Coughlin S.M.","year":"2003","unstructured":"Learned-Coughlin SM, Bergstr\u00f6m M, Savitcheva I, Ascher J, Schmith VD, L\u00e5ngstrom B.  \n activity of bupropion at the human dopamine transporter as measured by positron emission tomography.","journal-title":"Biol Psychiatry"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2005.08.016","volume":"89","author":"\u00c1rgyel\u00e1n M.","year":"2005","unstructured":"\u00c1rgyel\u00e1n M, Szab\u00f3 Z, Kany\u00f3 B.  Dopamine transporter availability in medication free and in bupropion treated depression: A 99mTc-TRODAT-1 SPECT study.","journal-title":"J Affect Disord"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00213-002-1166-3","volume":"163","author":"Meyer J.H.","year":"2002","unstructured":"Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S.  Bupropion occupancy of the dopamine transporter is low during clinical treatment.","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4088\/PCC.v06n0403","volume":"6","author":"Stahl S.M.","year":"2004","unstructured":"Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S.  A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4088\/PCC.v07n0305","volume":"7","author":"Fava M.","year":"2005","unstructured":"Fava M, Rush AJ, Thase ME.  15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0006-3223(99)00192-4","volume":"46","author":"Biederman J.","year":"1999","unstructured":"Biederman J, Spencer T.  Attention-deficit\/hyperactivity disorder (ADHD) as a noradrenergic disorder.","journal-title":"Biol Psychiatry"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.neuropsychologia.2009.07.005","volume":"47","author":"Banich M.T.","year":"2009","unstructured":"Banich MT, Burgess GC, Depue BE.  The neural basis of sustained and transient attentional control in young adults with ADHD.","journal-title":"Neuropsychologia"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/JCP.0b013e318174f92a","volume":"28","author":"Prince J.","year":"2008","unstructured":"Prince J.  Catecholamine dysfunction in attention-deficit\/hyperactivity disorder: An update.","journal-title":"J Clin Psychopharmacol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.biopsych.2011.02.036","volume":"69","author":"del Campo N.","year":"2011","unstructured":"del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW.  The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit\/hyperactivity disorder.","journal-title":"Biol Psychiatry"},{"key":"ref=27","author":"Stahl S.M.","year":"","unstructured":"Stahl SM.  Stahl's Essential Psychopharmacology: NeuroscientificBasic and Practical Applications. 4th edition ed. United States ofAmerica Cambridge University Press, New York; 2013. 471 - 502p."},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1196\/annals.1417.007","volume":"1129","author":"Brennan A.R.","year":"2008","unstructured":"Brennan AR, Arnsten AFT.  Neuronal mechanisms underlying attention deficit hyperactivity disorder: The influence of arousal on prefrontal cortical function.","journal-title":"Ann N Y Acad Sci"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00004583-199902000-00024","volume":"38","author":"Lombroso P.J.","year":"1999","unstructured":"Lombroso PJ, Arnsten AF.  Development of the cerebral cortex: XIV. Stress impairs prefrontal cortical function.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/mp.2010.97","volume":"16","author":"Volkow N.D.","year":"2011","unstructured":"Volkow ND, Wang GJ, Newcorn JH.  Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.","journal-title":"Mol Psychiatry"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biopsych.2006.04.042","volume":"61","author":"Scheres A.","year":"2007","unstructured":"Scheres A, Milham MP, Knutson B, Castellanos FX.  Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit\/hyperactivity disorder.","journal-title":"Biol Psychiatry"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biopsych.2005.03.036","volume":"57","author":"Spencer T.J.","year":"2005","unstructured":"Spencer TJ, Biederman J, Madras BK.  \n neuroreceptor imaging in attention-deficit\/hyperactivity disorder: a focus on the dopamine transporter.","journal-title":"Biol Psychiatry"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1550059415574622","volume":"47","author":"Fanella M.","year":"2016","unstructured":"Fanella M, Carn\u00ec M, Morano A.  Behavioral and movement disorders due to long-lasting myoclonic status epilepticus misdiagnosed as ADHD in a patient with juvenile myoclonic epilepsy: Electroclinical findings and related hemodynamic changes.","journal-title":"Clin EEG Neurosci"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1017\/S1092852900003278","volume":"13","author":"Stein M.A.","year":"2008","unstructured":"Stein MA.  Medical mimics and differential diagnosis in adult ADHD.","journal-title":"CNS Spectr"},{"key":"ref=35","first-page":"775","volume":"117","author":"Ushijima S.","year":"2014","unstructured":"Ushijima S.  Differential diagnosis of ADHD from personality disorders.","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-015-0604-y","volume":"17","author":"Marangoni C.","year":"2015","unstructured":"Marangoni C, De Chiara L, Faedda GL.  Bipolar disorder and ADHD: comorbidity and diagnostic distinctions.","journal-title":"Curr Psychiatry Rep"},{"key":"ref=37","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4471-4138-9","author":"Kooij J.J.S.","year":"2013","unstructured":"Kooij JJS.","journal-title":"Adult ADHD: Diagnostic Assessment and Treatment"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1087054714554933","volume":"21","author":"Milioni A.L.V.","year":"2014","unstructured":"Milioni ALV, Chaim TM, Cavallet M.  High IQ may \u201cmask\u201d the diagnosis of ADHD by compensating for deficits in executive functions in treatment-na\u00efve adults with ADHD.","journal-title":"J Atten Disord"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12888-015-0525-7","volume":"15","author":"Takeda T.","year":"2015","unstructured":"Takeda T, Tsuji Y, Uwatoko T, Kurita H.  Reliability and validity of ADHD diagnostic criteria in the Assessment System for Individuals with ADHD (ASIA): a Japanese semi-structured diagnostic interview.","journal-title":"BMC Psychiatry"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12888-016-0993-4","volume":"16","author":"Fasmer O.B.","year":"2016","unstructured":"Fasmer OB, Mjeldheim K, F\u00f8rland W.  Linear and non-linear analyses of Conner\u2019s Continuous Performance Test-II discriminate adult patients with attention deficit hyperactivity disorder from patients with mood and anxiety disorders.","journal-title":"BMC Psychiatry"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"e00330","DOI":"10.1002\/brb3.330","volume":"5","author":"Snyder S.M.","year":"2015","unstructured":"Snyder SM, Rugino TA, Hornig M, Stein MA.  Integration of an EEG biomarker with a clinician\u2019s ADHD evaluation.","journal-title":"Brain Behav"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/1087054713506041","volume":"19","author":"Makris N.","year":"2015","unstructured":"Makris N, Liang L, Biederman J.  Toward defining the neural substrates of ADHD: a controlled structural MRI study in medication-naive adults.","journal-title":"J Atten Disord"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/15622975.2010.518624","volume":"12","author":"Ahrendts J.","year":"2011","unstructured":"Ahrendts J, R\u00fcsch N, Wilke M.  Visual cortex abnormalities in adults with ADHD: a structural MRI study.","journal-title":"World J Biol Psychiatry"},{"key":"ref=44","first-page":"2","volume":"25","author":"Camilleri N.","year":"2013","unstructured":"Camilleri N, Makhoul S.  ADHD: from childhood into adulthood.","journal-title":"Malta Med J"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12618-009-0010-7","volume":"1","author":"Vitiello B.","year":"2009","unstructured":"Vitiello B.  ADHD psychopharmacology across the lifespan.","journal-title":"Curr Atten Disord Rep"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4088\/JCP.v65n1020d","volume":"65","author":"Weiss M.D.","year":"2004","unstructured":"Weiss MD, Weiss JR.  A guide to the treatment of adults with ADHD.","journal-title":"J Clin Psychiatry"},{"key":"ref=47","first-page":"315","volume":"42","author":"Rabito-Alc\u00f3n M.F.","year":"2014","unstructured":"Rabito-Alc\u00f3n MF, Correas-Lauffer J.  Treatment guidelines for attention deficit and hyperactivity disorder: a critical review.","journal-title":"Actas Esp Psiquiatr"},{"key":"ref=48","first-page":"675","volume":"52","author":"Hamedi M.","year":"2014","unstructured":"Hamedi M, Mohammdi M, Ghaleiha A.  Bupropion in adults with Attention-Deficit\/Hyperactivity Disorder: a randomized, double-blind study.","journal-title":"Acta Med Iran"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/cap.2016.0124","volume":"27","author":"Ng Q.X.","year":"2017","unstructured":"Ng QX.  A systematic review of the use of bupropion for attention-deficit\/hyperactivity disorder in children and adolescents.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","volume":"369","author":"Nutt D.","year":"2007","unstructured":"Nutt D, King LA, Saulsbury W, Blakemore C.  Development of a rational scale to assess the harm of drugs of potential misuse.","journal-title":"Lancet"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","volume":"111","author":"Wilens T.E.","year":"2003","unstructured":"Wilens TE, Faraone SV, Biederman J, Gunawardene S.  Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.","journal-title":"Pediatrics"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1542\/peds.111.1.97","volume":"111","author":"Barkley R.A.","year":"2003","unstructured":"Barkley RA, Fischer M, Smallish L, Fletcher K.  Does the treatment of attention-deficit\/hyperactivity disorder with stimulants contribute to drug use\/abuse? A 13-year prospective study.","journal-title":"Pediatrics"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/appi.ajp.2007.07091486","volume":"165","author":"Biederman J.","year":"2008","unstructured":"Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV.  Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study.","journal-title":"Am J Psychiatry"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2147\/NDT.S62714","volume":"10","author":"Maneeton N.","year":"2014","unstructured":"Maneeton N, Maneeton B, Intaprasert S, Woottiluk P.  A systematic review of randomized controlled trials of bupropion  methylphenidate in the treatment of attention-deficit\/hyperactivity disorder.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1037\/1064-1297.16.2.113","volume":"16","author":"Acheson A.","year":"2008","unstructured":"Acheson A, de Wit H.  Bupropion improves attention but does not affect impulsive behavior in healthy young adults.","journal-title":"Exp Clin Psychopharmacol"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1176\/appi.ajp.2012.11101521","volume":"169","author":"Cortese S.","year":"2012","unstructured":"Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP, Castellanos FX.  Toward Systems Neuroscience of ADHD: A Meta-Analysis of 55 fMRI Studies.","journal-title":"Am J Psychiatry"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0269881106073219","volume":"21","author":"Nutt D.","year":"2007","unstructured":"Nutt D, Fone K, Asherson P.  Evidence-based guidelines for management of attention-deficit\/hyperactivity disorder in adolescents in transition to adult services and in adults: Recommendations from the British Association for Psychopharmacology.","journal-title":"J Psychopharmacol"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-244X-10-67","volume":"10","author":"Kooij S.J.","year":"2010","unstructured":"Kooij SJ, Bejerot S, Blackwell A.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.","journal-title":"BMC Psychiatry"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.2042-7158.1977.tb11460.x","volume":"29","author":"Soroko F.E.","year":"1977","unstructured":"Soroko FE, Mehta NB, Maxwell RA, Ferris RM, Schroeder DH.  Bupropion hydrochloride ((+\/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.","journal-title":"J Pharm Pharmacol J Pharm Pharmacol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/S0968-0896(00)00210-8","volume":"8","author":"Yu H.","year":"2000","unstructured":"Yu H, Rothman RB, Dersch CM.  Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters.","journal-title":"Bioorg Med Chem"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","volume":"381","author":"Cozzi N.V.","year":"1999","unstructured":"Cozzi NV, Sievert MK, Shulgin AT.  Inhibition of plasma membrane monoamine transporters by \u03b2-ketoamphetamines.","journal-title":"Eur J Pharmacol"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/152399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T09:46:42Z","timestamp":1569232002000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/152399\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,12,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450118666170511145628","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}